Aldosterone: From integrative physiology to cellular biology and back

European Journal of Clinical Investigation

Volumn 34, Issue 10, 2004, Pages 653-655

  Ertl, Georg ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CYCLOOXYGENASE 2; SPIRONOLACTONE; VASCULAR CELL ADHESION MOLECULE 1;

ALDOSTERONE RELEASE; CARDIOVASCULAR AUTOREGULATION; FLUID BALANCE; HEART FAILURE; HEART MUSCLE FIBROSIS; HISTOPATHOLOGY; HUMAN; NONHUMAN; NOTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 7044245460     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2004.01403.x     Document Type: Note

References (11)

1. Satoh M, Nakamura M, Saitoh H, Satoh H, Akatsu T, Iwasaka J et al. Aldosteron synthase (CYP11B2) expression and myocardial fibrosis in the failing human heart. Clin Sci 2002;102:381-6.
2. Delles C, Erdmann J, Jacobi J, Hilgers KF, Fleck E, Regitz-Zagrosek V et al. Aldosterone synthase (CYP11B2)-344 C/T polymorphism is associated with left ventricular structure in human arterial hypertension. J Am Coll Cardiol 2001;37:878-84.
3. Hengstenberg C, Holmer SR, Mayer B, Löwel H, Engel S, Hense H-W et al. Evaluation of the aldosterone synthase (CYP11B2) gene polymorphism in patients with myocardial infarction. Hypertension 2000;35:704-9.
4. Delyani JA, Robinson EL, Rudolph AE. Effect of a selective aldosterone receptor antagonist in myocardial infarction. Am J Physiol Heart Circ Physiol 2001;50:H647-H54.
5. Zannad F, Dousset B, Alia F. Treatment of congestive heart failure. Interfering the aldosterone-cardiac extracellular matrix relationship. Hypertension 2001;38:1227-32.
6. Selye H. The general adaptation syndrome and the diseases of adaptation. J Clin Endocrinol 1946;6:117-230.
7. Friedman SM, Friedman CL. Observations on the role of the rat kidney in hypertension caused by deoxycorticosterone acetate. J Exp Med 1948;87:329.
8. Rocha R, Rudolph AE, Frierdich GE, Nachowiak DA, Kekec BK, Blomme EA et al. Aldosterone induces a vascular inflammatory phenotype in the rat heart. Am J Physiol Heart Circ Physiol 2002;283:H1802-10.
9. Bauersachs J. Aldosterone antagonism in heart failure: improvement of cardiac remodelling, endothelial dysfunction and platelet activation. Eur J Clin Invest 2004;34:649-52.
10. Schepkens H, Vanholder R, Billiouw J-M, Lameire N. Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors an spironolactone: an analysis of 25 cases. Am J Med 2001;110:438-41.
11. Juurlink DN, Mamdami MM, Lee DS, Kopp A, Austin PC, Laupacis A et al. Rate of hyperkalemia after publication of the randomized aldactone evaluation study. N Engl J Med 2004;351:543-51.